Neuren is significant undervalued ..
Neuren Pharma ( NEU.AX)
Marketcap: only 48 million A$
Price: 0,34 A$
Awesome Pipeline :
Glypromate MCI in CABG Phase 3 ongoing
NNZ-2566 Severe TBI (traumatic brain injury) Phase 2a (deal with US Army)
NNZ-2566 Mild/Mod TBI Phase 2
Motiva Post-stroke-Apathy Phase 2b
Taylor Collison
http://preset.sphilo.com/neuren/images/NEU%200708%20-%20Hamilton.pdf
By the end 1Q CY08, we expect Neuren to be running four major
efficacy trials; namely three Phase 2 trials for NNZ-2566 in
mild/moderate and severe TBI and Motiva™ in post stroke abulia/
depression coupled with the current Phase 3 trial for Glypromate® in
CABG. All indications potentially provide Neuren with first to market,
billion dollar opportunities. With a current market cap of $40.2m, Neuren
remains a solid value proposition in the sector, where FDA INDs for mid
to late stage clinical trials continues to remain a vexing proposition. We
maintain our Speculative Buy recommendation and price target of $1.30,
though expect to make changes to our valuation model once the
acquisition has closed, which we expect during the current Q.
- Forums
- ASX - By Stock
- IMU
- cheapest biotech stock on the asx
cheapest biotech stock on the asx
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.003(5.88%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.1¢ | 5.7¢ | 5.1¢ | $1.713M | 31.55M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 623619 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 623619 | 0.054 |
12 | 2041256 | 0.053 |
10 | 2155178 | 0.052 |
12 | 966719 | 0.051 |
36 | 3334835 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 50000 | 1 |
0.056 | 711256 | 6 |
0.057 | 1552780 | 8 |
0.058 | 1392228 | 10 |
0.059 | 1415548 | 10 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online